glp 1 weight loss insurance coverage What Covers Wegovy for Loss? (2026 Update) GLP-1s and The Payer Predicament

Changing the frequency of your injections, though, should only be done at the direction of your clinician

Research published in a 2025 narrative review found that GLP-1 medications can lead to muscle loss, micronutrient deficiencies, and digestive disruptions if nutritional needs aren't actively managed

That trial supports a 2024 FDA label expansion making semaglutide indicated for cardiovascular risk reduction in adults with overweight or obesity and prior CV disease

These questions are central to ongoing clinical and regulatory evaluation

AMPK activation increases glucose uptake in muscles, enhances insulin sensitivity, promotes fat oxidation, and improves mitochondrial function

However, the specific molecular mechanisms responsible for the effects of GLP-1 have still not been fully elucidated